1. Home

2021 Soft Matter Emerging Investigators: Unravelling the antimicrobial activity of peptide hydrogel systems: current and future perspectives

Our latest review paper has been published in the 2021 Soft Matter Emerging Investigators issue.

If you have an interest in peptide hydrogels or hydrogels within antimicrobial applications then please do check it out here!

We should hopefully have some exciting data to publish in this area in the coming months.

 

Related News


Advanced Science News Coverage and Advanced Healthcare Materials paper

Our recent research into using peptide hydrogels as long-acting injectable implants for HIV/AIDS drug delivery has be covered by Advanced Science News. This provides an oversight of our most recent publication within Advanced Healthcare Materials. A link to both can be found below: Advanced Science News Advanced Healthcare Materials    

Our EPSRC research selected as case study

Our research into long-acting peptide hydrogel drug delivery implants has been selected as a case study by the EPSRC for their Developing New Therapies Grand Challenge. Thanks to all of those involved in this multidisciplinary project and it’s great to see our work moving forward towards future use in patients. Please find a link to the […]

Exciting new lab facilities

We are currently moving into our new lab facilities in the School of Pharmacy’s McClay Research Centre, including a new synthesis and microbiology lab.

Our peptide hydrogel research wins Controlled Release Society’s 2020 People’s Choice Award

We are excited to hear our research on the use of peptide hydrogels for HIV/AIDs drug delivery won the overall CRS People’s Choice Award at the recent CRS virtual meeting. The presentation, as well as our other work, is available to conference participants by clicking the relevant title below.   Poster: Poster number 63.  Peptide-like […]

Funding for Medical Research Council: Confidence in Concept Project

We are happy to announce our group has received funding as part of the MRC CiC programme (£67,867) to study the use of antiretroviral drugs in HIV/AIDs prevention alongside our industry partners. Funding will enable a Research Fellow to work within our group on this project for one year. We should hopefully be in a […]

OUR RESEARCH IS FUNDED BY

Contact Us
  • +44 (0) 28 9097 2273
  • garry.laverty@qub.ac.uk
  • School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, Co. Antrim, N.Ireland. BT97BL
  • Get Directions
Quick Links
Laverty Lab